American Regent, Inc. announced the launch of Selenious Acid Injection, USP in a new concentration and vial size. The Selenious Acid family now includes a 12 mcg/2 mL (6 mcg/mL of selenium) single-dose vial designed for pediatric and neonatal patients less than 7 kg. Selenious Acid Injection is a trace element indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
"We are pleased to add the 12 mcg/2 mL (6 mcg/mL) single-dose vial of Selenious Acid to our family of FDA-approved products. Both Selenious Acid products available from American Regent have been developed to align with the American Society for Parenteral and Enteral Nutrition (ASPEN) Dosing Recommendations for trace elements supplementation. This launch demonstrates our continued commitment to the needs of special patient populations through the expansion of the Selenious Acid product line," stated Joann Gioia, Vice President and Chief Commercial Officer at American Regent, Inc.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!